Locally Advanced Or Metastatic Cholangiocarcinoma clinical trials

Explore recruiting locally advanced or metastatic cholangiocarcinoma clinical trials.

Recruiting locally advanced or metastatic cholangiocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Or Metastatic Cholangiocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label Early Access Phase 3b Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Netherlands, Austria, Germany, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Early Access Phase 3b Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Germany, Sweden, Netherlands, Austria, Italy, Spain +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1b/2, Safety Lead-in and Dose-Expansion, Open label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Activity of Ivosidenib in Combination with Durvalumab and Gemcitabine/Cisplatin as First-line Therapy in Participants with Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation

France, Germany, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Locally Advanced Or Metastatic Cholangiocarcinoma trials by city

Locally Advanced Or Metastatic Cholangiocarcinoma in Toronto Locally Advanced Or Metastatic Cholangiocarcinoma in Vancouver Locally Advanced Or Metastatic Cholangiocarcinoma in Montreal Locally Advanced Or Metastatic Cholangiocarcinoma in Calgary Locally Advanced Or Metastatic Cholangiocarcinoma in Edmonton Locally Advanced Or Metastatic Cholangiocarcinoma in Ottawa Locally Advanced Or Metastatic Cholangiocarcinoma in Winnipeg Locally Advanced Or Metastatic Cholangiocarcinoma in Quebec City Locally Advanced Or Metastatic Cholangiocarcinoma in Hamilton Locally Advanced Or Metastatic Cholangiocarcinoma in Kitchener Locally Advanced Or Metastatic Cholangiocarcinoma in London Locally Advanced Or Metastatic Cholangiocarcinoma in Halifax Locally Advanced Or Metastatic Cholangiocarcinoma in New York Locally Advanced Or Metastatic Cholangiocarcinoma in Los Angeles Locally Advanced Or Metastatic Cholangiocarcinoma in Chicago Locally Advanced Or Metastatic Cholangiocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease